Mitigation of inflammation-induced mood dysregulation by long-chain omega-3 fatty acids

This 2015 study found positive links between the ratio of Long-Chain Omega 6 fatty acids (LCn-6) to Long-Chain Omega 3 fatty acids (LCn-3) and low eicosapentaenic acid (EPA) and/or docosahexaenoic acid (DHA) biostasis with the incidence of mood disorders, major depressive disorder, and bipolar disorder. This is explained by the implication of LCn-3, EPA, and DHA possessing anti-inflammation properties. Therefore, it is predicted that increased intake in LCn-3 could relieve mood disorder through reducing immune-inflammatory signalling. [NPID: mood, happiness, well-being, omega-6 fatty acids, omega-3 fatty acids, DHA, EPA, major depressive disorder, MDD, bipolar disorder, BD, inflammation]

Year: 2015

Reference: McNamara R. K. (2015). Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids. Journal of the American College of Nutrition, 34 Suppl 1(0 1), 48–55. https://doi.org/10.1080/07315724.2015.1080527